Article: Altus Pharmaceuticals Inks Pact with Sandoz GmbH to Purchase Long-Term Growth Hormone Supply.

HEALTH AND BEAUTY CLOSE-UP-13 July 2008-Altus Pharmaceuticals Inks Pact with Sandoz GmbH to Purchase Long-Term Growth Hormone Supply(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com

Altus Pharmaceuticals a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, announced that it signed a long-term agreement to purchase recombinant human growth hormone (rhGH) for ALTU-238 for development and commercialization.

According to a release, Altus is developing ALTU-238 as a subcutaneously administered, long-acting formulation of rhGH that employs the Company's proprietary protein ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!